|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01136512 |
|
Date of registration:
|
02/06/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Metformin Use and Vitamin B12 Deficiency
|
|
Scientific title:
|
Metformin Use and Vitamin B12 Deficiency |
|
Date of first enrolment:
|
August 2007 |
|
Target sample size:
|
89 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01136512 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Cross-Sectional
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Neil Cohen, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Staten Island University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:Age 20-80; diagnosed with type 2 diabetes for at least 30 days
Exclusion Criteria:known vitamin B12 or folate deficiency; pernicious anemia; on vitamin
B12 therapy; hematological malignancy; methotrexate use; alcohol intake greater than two
drinks per day; vegetarian diet; previous gastric surgery; inflammatory bowel disease
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Type 2 Diabetes Mellitus
|
|
Vitamin B12 Deficiency
|
|
Primary Outcome(s)
|
|
Vitamin B12 level
[Time Frame: Yes]
|
|
Secondary Outcome(s)
|
|
methylmalonic acid
[Time Frame: No]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|